跳至主要内容
临床试验/CTRI/2023/04/051376
CTRI/2023/04/051376尚未招募3 期

ADD-ON EFFECTIVENESS OF BHŪNIMBÄ?DI GHANA CAPSULE ALONG WITH DIET AND LIFESTYLE MODIFICATION AMONG ADOLESCENT NAFLD - A RANDOMIZED CONTROLLED CLINICAL TRIA

All India Institute of Ayurveda, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient with liver stiffness 7.1 to 9.9 kPa in FibroScan.

排除标准

  • Patients with
  • 1.documented cause of chronic liver disease other than NASH
  • 2.suffering from anemia and other diseases that could increase ALT levels such as Hepatitis, Positive HBsAg, positive anti-human immunodeficiency virus, positive hepatitis C virus-RNA.
  • 3.History of drugs known to induce steatosis (systemic glucocorticoids, tetracycline, anabolic steroids, salicylates, tamoxifen, valproate, amiodarone, or prednisone).
  • 4.History of drugs known to induce affect body weight (Treatment with phentermine, lorcaserin orlistat, zonisamide, topiramate, bupropion, or naltrexone).
  • 5.Autoimmune liver disease, metabolic liver disease, Wilson disease.

研究者

发起方
All India Institute of Ayurveda, New Delhi

相似试验